Imperial College London Featured PhD Programmes
University of Portsmouth Featured PhD Programmes
Heriot-Watt University Featured PhD Programmes
University of Kent Featured PhD Programmes
University of Reading Featured PhD Programmes
"flow" AND "cytometry"×
10 miles

Cancer / Oncology (flow cytometry) PhD Projects, Programs & Scholarships

We have 31 Cancer / Oncology (flow cytometry) PhD Projects, Programs & Scholarships

  • "flow" AND "cytometry" ×
  • Cancer / Oncology×
  • clear all
Order by 
Showing 1 to 30 of 31
  Single-molecule fluorescence-activated cell sorting (smFACS): sorting cells molecule by molecule
  Research Group: Molecular and Nanoscale Phsyics
  Dr A Ponjavic
Application Deadline: 28 February 2020

Funding Type

PhD Type

This project will develop a novel microfluidic device that can characterise and sort cells, with unprecedented (single-molecule) sensitivity.
  New approaches to treating metastatic bone disease in breast and prostate cancer
  Dr A Riemen, Prof V Speirs, Prof A Johnstone
Application Deadline: 17 February 2020

Funding Type

PhD Type

Bone is a common metastatic site for breast and prostate cancers. Once metastasised to bones, one-year survival for prostate cancer is 29% (4) compared with 59% for breast cancer.
  Analysing immune responses to metastatic ovarian tumours to identify therapeutic targets
  Dr J H Caamano, Dr D Withers
Applications accepted all year round

Funding Type

PhD Type

Research interests/description of main research theme. Ovarian cancer remains the most lethal gynaecological malignancy for women over 50 years old (1).
  Investigating how ovarian tumours avoid immune responses in cancer patients
  Dr J H Caamano, Dr D Withers
Applications accepted all year round

Funding Type

PhD Type

Research interests/description of main research theme. Ovarian cancer remains the most lethal gynaecological malignancy for women over 50 years old (1).
  Transglutaminase 2 (TG2) as a novel cancer biomarker and target for chemotherapy
  Research Group: Biomedical Research Group
  Dr P Coussons, Dr C Pike
Applications accepted all year round

Funding Type

PhD Type

Research Group. Biomedical Research Group. https://www.anglia.ac.uk/science-and-engineering/research/institutes-and-groups/biomedical.
  Funded Research MPhil (fees-only) on Epigenetics of Acute Myeloid Leukaemia
  Dr C Pina
Application Deadline: 28 February 2020

Funding Type

PhD Type

The Centre for Genome Engineering and Maintenance (CenGEM) and Division of Biosciences at Brunel University London is offering a funded MPhil research studentship (fees-only) for the investigation of the cross-talk between DNA and histone modifications in the evolution of Acute Myeloid Leukaemia.
  ExomiR resetting of the energy profile in Hepatocellular Cancer (HCC) via the mitochondrial proteome
  Prof N Heaton, Dr S E Khorsandi
Application Deadline: 30 April 2020

Funding Type

PhD Type

Project description. The issue/problem. Hepatocellular cancer (HCC) is a primary liver cancer and one of the commonest cancers in the world.
  Micro-environmental Interactions And Non-Coding RNAs In The Biology Of B Cell Leukemia
  Prof M Mráz
Application Deadline: 20 February 2020

Funding Type

PhD Type

We are looking for motivated PhD students for a project funded by the prestigious ERC (European Research Council) Grant (laboratory of Assoc.
  Testing the function of immune suppressive cytokines and cells in bone metastasis
  Assoc Prof B Parker
Applications accepted all year round

Funding Type

PhD Type

Bone metastasis is a common occurrence in breast and prostate cancer that leads to patient morbidity and, in many cases, mortality.
  The role of the breast microenvironment in suppressing early cancer invasion
  Assoc Prof B Parker, Dr D Zanker
Applications accepted all year round

Funding Type

PhD Type

Ductal carcinoma in situ (DCIS) is a pre-invasive stage of breast cancer, whereby the tumour cells remain restrained by myoepithelial cells that surround breast ducts.
  Therapy-induced senescence and stemness in ovarian cancer
  Prof R. Pearson, Dr K Chan
Applications accepted all year round

Funding Type

PhD Type

Cellular senescence is a stress response characterized by a robust cell cycle arrest and is a brake for malignant transformation.
  Structure based design of novel warheads for use in peptide-drug conjugates
  Dr S Butterworth, Dr A Tirella, Dr D Wiseman
Applications accepted all year round

Funding Type

PhD Type

Chronic Myelomonocytic Leukaemia (CMML) is an orphan disease defined by myeloid dysplasia, myeloproliferation and a malignant expansion of classical monocytes.
  The role of the microenvironment in regulating breast cancer metastatic colonisation
  Dr R Clarke, Dr Ciara O'Brien, Dr R Eyre
Applications accepted all year round

Funding Type

PhD Type

The metastatic spread of breast cancer cells and their colonisation of important organs is the cause of death in 95% of breast cancer.
  Targeting steroid metabolism to block colorectal cancer proliferation
  Dr P Foster, Dr L Cox
Applications accepted all year round

Funding Type

PhD Type

Our group is a world leader in targeting specific aspects of steroid metabolism to block cancer growth. Our research has been instrumental in the successful pre-clinical and clinical development of various novel anti-cancer compounds.
  Enhancing Oncolytic Virus-induced Immunotherapy using Eicosapentaenoic Acid (EPA)
  Dr F Errington-Mais, Dr MA Volpato
Applications accepted all year round

Funding Type

PhD Type

Breast cancer is the most commonly diagnosed cancer in women with triple-negative breast cancer (TNBC) having the worst prognosis, highest death rate and lowest overall survival.
  Metabolic reprogramming in cancer: starving tumors of essential nutrients to promote cell death
  Dr S Papa
Applications accepted all year round

Funding Type

PhD Type

All the cells in our bodies are programmed to die. As they get older, our cells accumulate toxic molecules that make them sick. In response, they eventually break down and die, clearing the way for new, healthy cells to grow.
  Molecular modelling and analysis of plasma cell cancers
  Dr R Tooze, Dr G Doody, Dr R Owen
Application Deadline: 10 March 2020

Funding Type

PhD Type

Plasma cell neoplasms, including multiple myeloma, are cancers of the immune system that remain largely incurable despite major advances in therapy.
  Personalised anti-viral immunotherapies for hepatitis B and C virus-associated hepatocellular carcinoma
  Dr A Samson, Dr S Griffin
Application Deadline: 28 February 2020

Funding Type

PhD Type

Hepatocellular carcinoma (HCC) is a cancer of hepatocytes commonly caused by hepatitis B and C virus (HBV/HCV) infections. Only 12% of HCC patients survive for five-years, due to late diagnosis and inadequate non-personalised therapies.
  Pre-clinical investigations of POLQ inhibitors
  Dr G Higgins, Prof T Humphrey
Application Deadline: 3 March 2020

Funding Type

PhD Type

THE PROJECT. The aim of our research is to improve radiotherapy for cancer patients by making tumour cells more sensitive to radiation without affecting the sensitivity of normal cells.
  The role of the AXL Receptor Tyrosine Kinase in the DNA damage response
  Prof A Giaccia, Prof E Hammond
Application Deadline: 3 March 2020

Funding Type

PhD Type

THE PROJECT. The Axl receptor tyrosine kinase is a critical driver of tumour progression and drug resistance, and has resulted in combining Axl inhibitors with both targeted and cytotoxic therapies.
  Defining protein degradation machinery in the endoplasmic reticulum underlying resistance mechanisms in cancer
  Assoc Prof J Christianson, Prof Udo Oppermann
Application Deadline: 3 March 2020

Funding Type

PhD Type

Cellular stress is a hallmark of cancers. The restorative homeostatic response mechanisms that often become constitutively engaged, serve to adapt populations to hyperproliferative and metabolically dysregulated states, stabilise malignancy, and elevate resistance to therapeutic agents.
  Academic Endocrine Unit: investigating the molecular basis of endocrine and metabolic disorders that principally affect calcium and phosphate homeostasis.
  Prof R Thakker, Dr K Lines, Dr M Stevenson, Dr K Kooblall
Application Deadline: 24 July 2020

Funding Type

PhD Type

Other Potential Supervisors. Dr Asha Bayliss. The Academic Endocrine Unit investigates the molecular basis of endocrine and metabolic disorders that principally affect calcium and phosphate homeostasis.
  Identification of key determinants affecting the quality of human Cancer specific cytotoxic T cells
  Prof T Dong
Application Deadline: 24 July 2020

Funding Type

PhD Type

The main objective of my group’s research is to focus on the functional aspects of the antigen specific T cells and study the factors affecting Cytotoxic T cells in controlling cancer development.
  Single Cell Biology of Hematopoietic Stem- and Progenitor Cells in Blood Cancer and Ageing
  Prof Claus Nerlov, Prof P Vyas
Application Deadline: 24 July 2020

Funding Type

PhD Type

The focus of the Nerlov laboratory is to use single cell genomics and functional analysis, combined with advanced mouse genetics, to study the function of hematopoietic stem– and progenitor cells in normal development and during ageing.
  Identification of key determinants affecting the quality of human Cancer specific cytotoxic T cells
  Prof T Dong
Application Deadline: 24 July 2020

Funding Type

PhD Type

The main objective of my group’s research is to focus on the functional aspects of the antigen specific T cells and study the factors affecting Cytotoxic T cells in controlling cancer development.
  Single Cell Biology of Hematopoietic Stem- and Progenitor Cells in Blood Cancer and Ageing
  Prof Claus Nerlov, Prof P Vyas
Application Deadline: 24 July 2020

Funding Type

PhD Type

The focus of the Nerlov laboratory is to use single cell genomics and functional analysis, combined with advanced mouse genetics, to study the function of hematopoietic stem– and progenitor cells in normal development and during ageing.
  Designing novel composite polysaccharide nanoparticles for combined diagnosis and treatment of cancers
  Dr E Barbu, Dr A Lalatsa
Applications accepted all year round

Funding Type

PhD Type

Cancer continues to impose a vast burden with regard to financial costs as well as human suffering but the progress in its treatment is hindered by the limited selectivity and significant side-effects that the current chemotherapy demonstrates, representing a major challenge for modern drug delivery.
  Cell competition as a tumour suppressor in leukaemia
  Dr C Slape
Application Deadline: 28 February 2020

Funding Type

PhD Type

Leukaemia is a devastating disease that, despite advances in treatment, still carries a poor prognosis, and as such the disease represents a huge burden on the health care system.
  Platelet-cell interactions: Platelets beyond thrombosis and haemostasis
  Dr A Pollitt
Applications accepted all year round

Funding Type

PhD Type

"Platelets play a key role in the prevention of bleeding following blood vessel damage.
  Effects of Radiotherapy on CAR T-cell function over time
  Dr M Pule, Dr C Roddie
Application Deadline: 16 March 2020

Funding Type

PhD Type

Summary. Chimeric antigen receptors (CARs) graft the specificity of an antibody onto the dynamic and persisting effector function of a T-cell.
Show 10 15 30 per page


FindAPhD. Copyright 2005-2020
All rights reserved.